Conclusion
the dossier summarised in one paragraphThe computed 12-month bankruptcy probability of Taikun Pharmaceutical Technology is 1.8% (average). The company has been active since 2024 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.
Based on State Gazette and CBE data.
Financials
No processed annual-account figures available.
To financials
People & board
No director data processed yet.
To directors Publicationslatest 14-08-2024
1
publications in the State GazetteRegistered office moved within ZwijnaardeAll publications & acts Network & structure
No network or structure data processed.
To structure
Trust signals
3 signalsYoung company
Founded in 2024 — under 3 years, statistically higher risk.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad.
Administratively compliant
No FOD Economie strikeouts (UBO, accounts, address, activity).
Administrative Flags
0 events
No administrative flags
Bankruptcy probability (12 mo)
Checked model v1 · free for everyone1.8%
Average
0%0,5%1,5%4%10%≥25%
Young company
+Multiple establishment units
+Lower-risk legal form
−
Statistical estimate based on public sources — not credit advice nor a finding of fact. How do we compute this?
Company registry (CBE)
Crossroads BankActivities
Vervaardiging van farmaceutische grondstoffen21100Vervaardiging van farmaceutische grondstoffen21100Opslag52100Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied72109Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied72190
Primary activity highlighted.
Names & trade names
| Legal nameNL | Taikun Pharmaceutical Technology |
Registered office
Frieda Saeysstraat 3
9052 Gent, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.